Cargando…

Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus

BACKGROUND: Hepatitis C virus (HCV) infection represents a worldwide health threat that still needs efficient protective vaccine and/or effective drug. The traditional medicine, such as camel milk, is heavily used by the large sector of HCV patients to control the infection due to the high cost of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Redwan, Elrashdy M, EL-Fakharany, Esmail M, Uversky, Vladimir N, Linjawi, Mustafa H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086701/
https://www.ncbi.nlm.nih.gov/pubmed/24993815
http://dx.doi.org/10.1186/1472-6882-14-219
_version_ 1782324839578599424
author Redwan, Elrashdy M
EL-Fakharany, Esmail M
Uversky, Vladimir N
Linjawi, Mustafa H
author_facet Redwan, Elrashdy M
EL-Fakharany, Esmail M
Uversky, Vladimir N
Linjawi, Mustafa H
author_sort Redwan, Elrashdy M
collection PubMed
description BACKGROUND: Hepatitis C virus (HCV) infection represents a worldwide health threat that still needs efficient protective vaccine and/or effective drug. The traditional medicine, such as camel milk, is heavily used by the large sector of HCV patients to control the infection due to the high cost of the available standard therapy. Camel milk contains lactoferrin, which plays an important and multifunctional role in innate immunity and specific host defense against microbial infection. Continuing the analysis of the effectiveness of camel lactoferrin against HCV, the current study aimed to separate and purify the native N- and C-lobes from the proteolytically cleaved camel lactoferrin (cLF) and to compare their in vitro activities against the HCV infection in Huh7.5 cells in order to determine the most active domain. METHODS: Lactoferrin and its digested N- and C-lobes were purified by Mono S 5/50 GL column and Superdex 200 5/150 column. The purified proteins were assessed through three venues: 1. To inhibit intracellular replication, HCV infected cells were treated with the proteins at different concentrations and time intervals; 2. The proteins were directly incubated with the viral particles (neutralization) and then such neutralized viruses were used to infect cells; 3. The cells were protected with proteins before exposure to the virus. The antiviral potentials of the cLf and its lobes were determined using three techniques: 1. RT-nested PCR, 2. Real-time PCR, and 3. Flow cytometry. RESULTS: N- and C-lobes were purified in two consecutive steps; using Mono-S and Superdex 200 columns. The molecular mass of N- and C-lobes was about 40 kDa. cLF and its lobes could prevent HCV entry into Huh 7.5 cells with activity reached 100% through direct interaction with the virus. The inhibition of intracellular viral replication by N-lobe is 2-fold and 3-fold more effective than that of the cLF and C-lobe, respectively. CONCLUSION: Generated native N- and C-lobes from camel lactoferrin demonstrated a range of noticeably different potentials against HCV cellular infectivity. The anti-HCV activities were sorted as N-lobe > cLf > C-lobe.
format Online
Article
Text
id pubmed-4086701
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40867012014-07-09 Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus Redwan, Elrashdy M EL-Fakharany, Esmail M Uversky, Vladimir N Linjawi, Mustafa H BMC Complement Altern Med Research Article BACKGROUND: Hepatitis C virus (HCV) infection represents a worldwide health threat that still needs efficient protective vaccine and/or effective drug. The traditional medicine, such as camel milk, is heavily used by the large sector of HCV patients to control the infection due to the high cost of the available standard therapy. Camel milk contains lactoferrin, which plays an important and multifunctional role in innate immunity and specific host defense against microbial infection. Continuing the analysis of the effectiveness of camel lactoferrin against HCV, the current study aimed to separate and purify the native N- and C-lobes from the proteolytically cleaved camel lactoferrin (cLF) and to compare their in vitro activities against the HCV infection in Huh7.5 cells in order to determine the most active domain. METHODS: Lactoferrin and its digested N- and C-lobes were purified by Mono S 5/50 GL column and Superdex 200 5/150 column. The purified proteins were assessed through three venues: 1. To inhibit intracellular replication, HCV infected cells were treated with the proteins at different concentrations and time intervals; 2. The proteins were directly incubated with the viral particles (neutralization) and then such neutralized viruses were used to infect cells; 3. The cells were protected with proteins before exposure to the virus. The antiviral potentials of the cLf and its lobes were determined using three techniques: 1. RT-nested PCR, 2. Real-time PCR, and 3. Flow cytometry. RESULTS: N- and C-lobes were purified in two consecutive steps; using Mono-S and Superdex 200 columns. The molecular mass of N- and C-lobes was about 40 kDa. cLF and its lobes could prevent HCV entry into Huh 7.5 cells with activity reached 100% through direct interaction with the virus. The inhibition of intracellular viral replication by N-lobe is 2-fold and 3-fold more effective than that of the cLF and C-lobe, respectively. CONCLUSION: Generated native N- and C-lobes from camel lactoferrin demonstrated a range of noticeably different potentials against HCV cellular infectivity. The anti-HCV activities were sorted as N-lobe > cLf > C-lobe. BioMed Central 2014-07-03 /pmc/articles/PMC4086701/ /pubmed/24993815 http://dx.doi.org/10.1186/1472-6882-14-219 Text en Copyright © 2014 Redwan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Redwan, Elrashdy M
EL-Fakharany, Esmail M
Uversky, Vladimir N
Linjawi, Mustafa H
Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus
title Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus
title_full Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus
title_fullStr Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus
title_full_unstemmed Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus
title_short Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus
title_sort screening the anti infectivity potentials of native n- and c-lobes derived from the camel lactoferrin against hepatitis c virus
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086701/
https://www.ncbi.nlm.nih.gov/pubmed/24993815
http://dx.doi.org/10.1186/1472-6882-14-219
work_keys_str_mv AT redwanelrashdym screeningtheantiinfectivitypotentialsofnativenandclobesderivedfromthecamellactoferrinagainsthepatitiscvirus
AT elfakharanyesmailm screeningtheantiinfectivitypotentialsofnativenandclobesderivedfromthecamellactoferrinagainsthepatitiscvirus
AT uverskyvladimirn screeningtheantiinfectivitypotentialsofnativenandclobesderivedfromthecamellactoferrinagainsthepatitiscvirus
AT linjawimustafah screeningtheantiinfectivitypotentialsofnativenandclobesderivedfromthecamellactoferrinagainsthepatitiscvirus